UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

Journal of clinical oncology, 2005-06, Vol.23 (16), p.3668-3675

2005

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer

International journal of gynecological cancer, 2016-06, Vol.26 (5), p.918-923

2016

Link zum Volltext

Verfügbarkeit prüfen

MRI of ovarian torsion: Correlation of imaging features with the presence of perifollicular hemorrhage and ovarian viability

European journal of radiology, 2016-11, Vol.85 (11), p.2064-2071

2016

Link zum Volltext

Verfügbarkeit prüfen

The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer

Gynecologic oncology, 2007-02, Vol.104 (2), p.401-405

2007

Link zum Volltext

Verfügbarkeit prüfen

Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study

Clinical cancer research, 2022-01, Vol.28 (1), p.36-44

2022

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations

Journal of the advanced practitioner in oncology, 2019-07, Vol.10 (5), p.428-439

2019

Link zum Volltext

Verfügbarkeit prüfen

Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma

Modern pathology, 2015-01, Vol.28 (1), p.118-127

2015

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review

Journal of Cancer, 2010-01, Vol.1 (1), p.27-31

2010

Link zum Volltext

Verfügbarkeit prüfen

Tubal origin of ovarian endometriosis

Modern pathology, 2014-08, Vol.27 (8), p.1154-1162

2014

Link zum Volltext

Verfügbarkeit prüfen

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

Gynecologic oncology, 2006-07, Vol.102 (1), p.92-97

2006

Link zum Volltext

Verfügbarkeit prüfen

Secretory cell expansion with aging: Risk for pelvic serous carcinogenesis

Gynecologic oncology, 2013-12, Vol.131 (3), p.555-560

2013

Link zum Volltext

Verfügbarkeit prüfen

PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy

Journal of hematology and oncology, 2013-08, Vol.6 (1), p.60-60, Article 60

2013

Link zum Volltext

Verfügbarkeit prüfen

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer

Gynecologic oncology, 2005-12, Vol.99 (3), p.689-695

2005

Link zum Volltext

Verfügbarkeit prüfen

Struma ovarii simulating ovarian sertoli cell tumor: a case report with literature review

International journal of clinical and experimental pathology, 2013-01, Vol.6 (3), p.516-520

2013

Link zum Volltext

Verfügbarkeit prüfen

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

The lancet oncology, 2017, Vol.18 (1), p.75-87

2017

Link zum Volltext

Verfügbarkeit prüfen

Amniotic fluid embolism presenting after uterine manipulation under general anesthesia: A case with a positive outcome

Resuscitation, 2008-04, Vol.77 (1), p.145-146

2008

Link zum Volltext

Verfügbarkeit prüfen

Delay in treatment of invasive cervical cancer due to intimate partner violence

Gynecologic oncology, 2005-11, Vol.99 (2), p.507-509

2005

Link zum Volltext

Verfügbarkeit prüfen

Incidence of hypersensitivity reactions to carboplatin or paclitaxel in patients with ovarian, Fallopian tube, or primary peritoneal cancer with or without BRCA1 or BRCA2 mutations

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e18758-e18758

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract GMM-048: CTDNA RESPONSE TO THE PARP INHIBITOR RUCAPARIB PREDICTS PROGRESSION-FREE SURVIVAL AND BEST OVERALL RESPONSE ON THE ARIEL2 TRIAL

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.GMM-048-GMM-048

2019

Link zum Volltext

Verfügbarkeit prüfen

Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5513-5513

2019

Link zum Volltext

Verfügbarkeit prüfen

Pelvic Lymph Node Count is an Important Prognostic Variable for FIGO Stage I and II Endometrial Carcinoma With High-Risk Histology

Obstetrical & gynecological survey, 2006-10, Vol.61 (10), p.642-644

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract AP27: FEASIBILITY OF MONITORING RESPONSE TO THE PARP INHIBITOR RUCAPARIB WITH TARGETED DEEP SEQUENCING OF CIRCULATING TUMOR DNA (CTDNA) IN WOMEN WITH HIGH GRADE OVARIAN CARCINOMA ON THE ARIEL2 TRIAL

Clinical cancer research, 2017-06, Vol.23 (11_Supplement), p.AP27-AP27

2017

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high-grade serous carcinoma on the ARIEL2 trial

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5549-5549

2016

Link zum Volltext

Verfügbarkeit prüfen

Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5540-5540

2016

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review

Journal of Cancer, 2010, Vol.1, p.27-31

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)
Berichte
(1)

Sprache

Englisch
(27)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Female
(17)
Humans
(17)
Oncology
(14)
Middle Aged
(10)
Adult
(9)
Aged
(9)
Obstetrics & Gynecology
(7)
Aged, 80 And Over
(6)
Endometrial Neoplasms - Pathology
(6)
Neoplasm Staging
(6)
Ovarian Cancer
(5)
Retrospective Studies
(5)
Endometrial Neoplasms - Surgery
(4)
Obstetrics And Gynecology
(4)
Ovarian Neoplasms - Drug Therapy
(4)
Ovarian Neoplasms - Pathology
(4)
Prognosis
(4)
Antineoplastic Agents - Pharmacology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer

MRI of ovarian torsion: Correlation of imaging features with the presence of perifollicular hemorrhage and ovarian viability

The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer

Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study

Incidence of Hypersensitivity Reactions to Carboplatin or Paclitaxel in Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer With or Without BRCA1 or BRCA2 Mutations

Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma

Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review

Tubal origin of ovarian endometriosis

Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology

Secretory cell expansion with aging: Risk for pelvic serous carcinogenesis

PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy

Resection of lymph node metastases influences survival in stage IIIC endometrial cancer

Struma ovarii simulating ovarian sertoli cell tumor: a case report with literature review

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

Amniotic fluid embolism presenting after uterine manipulation under general anesthesia: A case with a positive outcome

Delay in treatment of invasive cervical cancer due to intimate partner violence

Incidence of hypersensitivity reactions to carboplatin or paclitaxel in patients with ovarian, Fallopian tube, or primary peritoneal cancer with or without BRCA1 or BRCA2 mutations

Abstract GMM-048: CTDNA RESPONSE TO THE PARP INHIBITOR RUCAPARIB PREDICTS PROGRESSION-FREE SURVIVAL AND BEST OVERALL RESPONSE ON THE ARIEL2 TRIAL

Adavosertib with chemotherapy (CT) in patients (pts) with platinum-resistant ovarian cancer (PPROC): An open label, four-arm, phase II study

Pelvic Lymph Node Count is an Important Prognostic Variable for FIGO Stage I and II Endometrial Carcinoma With High-Risk Histology

Abstract AP27: FEASIBILITY OF MONITORING RESPONSE TO THE PARP INHIBITOR RUCAPARIB WITH TARGETED DEEP SEQUENCING OF CIRCULATING TUMOR DNA (CTDNA) IN WOMEN WITH HIGH GRADE OVARIAN CARCINOMA ON THE ARIEL2 TRIAL

Feasibility of monitoring response to the PARP inhibitor rucaparib with targeted deep sequencing of circulating tumor DNA (ctDNA) in women with high-grade serous carcinoma on the ARIEL2 trial

Refinement of prespecified cutoff for genomic loss of heterozygosity (LOH) in ARIEL2 part 1: A phase II study of rucaparib in patients (pts) with high grade ovarian carcinoma (HGOC)

Ovarian cancer metastatic to the breast presenting as inflammatory breast cancer: a case report and literature review

Suchergebnisse filtern